Table 4.
Univariate and multivariate regression analysis of taVNS parameters associated with the number of AEs reported by patients undergoing active taVNS in the included studies.
Beta-coefficient | 95% CI | p-value | |
---|---|---|---|
Univariate analysis | |||
Age | 0.001 | − 0.002 to 0.006 | 0.422 |
Gender | 0.275 | − 0.037 to 0.588 | 0.082 |
Number of subjects | 0.001 | − 0.0003 to 0.004 | 0.099 |
Duration | 0.151 | 0.049 to 0.252 | 0.004 |
Number of sessions | 0.126 | 0.019 to 0.232 | 0.022 |
Intensity | 0.070 | − 0.067 to 0.208 | 0.312 |
Frequency | 0.083 | − 0.032 to 0.199 | 0.155 |
Pulse width | − 0.129 | − 0.284 to 0.024 | 0.096 |
Side | − 0.058 | − 0.230 to 0.114 | 0.501 |
Devices | 0.149 | 0.010 to 0.289 | 0.036 |
Multivariate analysis | R2 = 0.1882 | ||
Age | -0.5e-5 | − 3e-5 to 2e-5 | 0.727 |
Gender | 0.053 | − 0.113 to 0.220 | 0.520 |
Duration | 0.285 | 0.122 to 0.448 | 0.001 |
CI: confidence interval.